Bexinib 5mg Tablet | Axitinib 5mg | Anti-Cancer Tyrosine Kinase Inhibitor | For Advanced Kidney Cancer (Renal Cell Carcinoma) | Prescription Required | 14 Tablets | Adley Formulations

Product Description

Prescription Notice Prescription-only medicine. Sold only against a valid prescription from a registered oncologist or medical practitioner. To be used only under medical supervision. Description Bexinib 5mg Tablet contains Axitinib (5 mg per tablet), a targeted anti-cancer medicine from the tyrosine kinase inhibitor group. It blocks VEGF receptors, which tumours use to build new blood vessels, and so helps slow the growth and spread of cancer cells. It is prescribed for advanced renal cell carcinoma (kidney cancer), typically after failure of a prior systemic therapy, as decided by the treating oncologist. Each pack contains 14 tablets.